Does Rallies show 13F holders for GENI?

Yes. Rallies tracks hedge fund and 13F ownership data for GENI, including fund names, share counts, latest tracked quarter, and position changes when available.

Is GENI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GENI. It does not provide personalized investment advice.

GENI (Genius Sports Limited) Stock Analysis - Hedge Fund Holdings

Genius Sports Limited (GENI) is a publicly traded Communication Services sector company. As of May 20, 2026, GENI trades at $5.08 with a market cap of $1.38B and a P/E ratio of 0.00. GENI moved +0.10% today. Year to date, GENI is -55.42%; over the trailing twelve months it is -49.45%. Its 52-week range spans $3.83 to $13.73. Analyst consensus is strong buy with an average price target of $9.45. Rallies surfaces GENI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns GENI stock?

Hedge funds tracked by Rallies that own GENI include Glenview Capital, 1060 Capital, Panagora Asset, Centerbook Partners, and Chilton Investment. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Genius Sports Limited.

GENI Key Metrics

Key financial metrics for GENI
Metric	Value
Price	$5.08
Market Cap	$1.38B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$13.73
52-Week Low	$3.83
Volume	3.61M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding GENI

Glenview Capital holds 8.56M shares of GENI, changed +321.68% as of Mar 31, 2026.
1060 Capital holds 700.00K shares of GENI, changed +222.00% as of Mar 31, 2025.
Panagora Asset holds 236.61K shares of GENI, changed +0.00% as of Mar 31, 2026.
Centerbook Partners holds 99.43K shares of GENI, changed -54.48% as of Mar 31, 2026.
Chilton Investment holds 17.89K shares of GENI, changed +0.00% as of Dec 31, 2024.

Latest GENI News

Genius Sports Projects $170.6M Q1 Revenue, Full-Year Sales Revised to $813.8M — May 6, 2026
Genius Sports Sued for AI-Driven Microbetting Fueling 98% US Betting Market — Mar 24, 2026
Genius Sports Posts $669M 2025 Revenue with 31% Growth, Guides 22% 2026 Rise — Mar 4, 2026
Genius Sports Guides 2025 Revenue to $655M, Q3 Media Grows 90% — Feb 28, 2026
Genius Sports, NBC Regional Networks Unveil Exclusive AR Ad Platform for NBA — Feb 26, 2026

GENI Analyst Consensus

13 analysts cover GENI: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.45.

Common questions about GENI

Who owns GENI stock?: Hedge funds tracked by Rallies that own GENI include Glenview Capital, 1060 Capital, Panagora Asset, Centerbook Partners, and Chilton Investment. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Genius Sports Limited.
Does Rallies show 13F holders for GENI?: Yes. Rallies tracks hedge fund and 13F ownership data for GENI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is GENI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GENI. It does not provide personalized investment advice.